123 related articles for article (PubMed ID: 29483289)
21. Development of a high-affinity anti-bovine PD-1 rabbit-bovine chimeric antibody using an efficient selection and large production system.
Okagawa T; Konnai S; Goto S; Sajiki Y; Ganbaatar O; Watari K; Nakamura H; Wang CX; Tachibana T; Kato Y; Kameda Y; Kohara J; Terasaki N; Kubota M; Takeda A; Takahashi H; Suzuki Y; Maekawa N; Murata S; Ohashi K
Vet Res; 2023 Sep; 54(1):82. PubMed ID: 37759311
[TBL] [Abstract][Full Text] [Related]
22. Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus.
Nakamura H; Konnai S; Okagawa T; Maekawa N; Sajiki Y; Watari K; Kamitani K; Saito M; Kato Y; Suzuki Y; Murata S; Ohashi K
J Virol; 2023 Jan; 97(1):e0143022. PubMed ID: 36598199
[TBL] [Abstract][Full Text] [Related]
23. Metabolomic changes in polyunsaturated fatty acids and eicosanoids as diagnostic biomarkers in Mycobacterium avium ssp. paratuberculosis (MAP)-inoculated Holstein-Friesian heifers.
Taylor EN; Beckmann M; Hewinson G; Rooke D; Mur LAJ; Koets AP
Vet Res; 2022 Sep; 53(1):68. PubMed ID: 36056402
[TBL] [Abstract][Full Text] [Related]
24. Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.
Sajiki Y; Konnai S; Okagawa T; Maekawa N; Goto S; Kohara J; Nitanai A; Takahashi H; Kubota K; Takeda H; Murata S; Ohashi K
PLoS One; 2022; 17(3):e0263660. PubMed ID: 35263339
[TBL] [Abstract][Full Text] [Related]
25. A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients.
Jenum S; Tonby K; Rueegg CS; Rühwald M; Kristiansen MP; Bang P; Olsen IC; Sellæg K; Røstad K; Mustafa T; Taskén K; Kvale D; Mortensen R; Dyrhol-Riise AM
Nat Commun; 2021 Nov; 12(1):6774. PubMed ID: 34811370
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of interleukin-2 production by bovine peripheral blood mononuclear cells treated with the combination of anti-programmed death-ligand 1 and cytotoxic T lymphocyte antigen 4 chimeric monoclonal antibodies.
Watari K; Konnai S; Okagawa T; Maekawa N; Sajiki Y; Kato Y; Suzuki Y; Murata S; Ohashi K
J Vet Med Sci; 2022 Jan; 84(1):6-15. PubMed ID: 34789592
[TBL] [Abstract][Full Text] [Related]
27. Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade.
Ganbaatar O; Konnai S; Okagawa T; Nojima Y; Maekawa N; Ichikawa Y; Kobayashi A; Shibahara T; Yanagawa Y; Higuchi H; Kato Y; Suzuki Y; Murata S; Ohashi K
Immun Inflamm Dis; 2021 Dec; 9(4):1573-1583. PubMed ID: 34414683
[TBL] [Abstract][Full Text] [Related]
28. Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression.
Sajiki Y; Konnai S; Ikenaka Y; Gulay KCM; Kobayashi A; Parizi LF; João BC; Watari K; Fujisawa S; Okagawa T; Maekawa N; Logullo C; da Silva Vaz I; Murata S; Ohashi K
Sci Rep; 2021 Jan; 11(1):1063. PubMed ID: 33441793
[TBL] [Abstract][Full Text] [Related]
29. The Suppression of Th1 Response by Inducing TGF-β1 From Regulatory T Cells in Bovine Mycoplasmosis.
Sajiki Y; Konnai S; Goto S; Okagawa T; Ohira K; Shimakura H; Maekawa N; Gondaira S; Higuchi H; Tajima M; Hirano Y; Kohara J; Murata S; Ohashi K
Front Vet Sci; 2020; 7():609443. PubMed ID: 33344537
[TBL] [Abstract][Full Text] [Related]
30. PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade.
Ganbaatar O; Konnai S; Okagawa T; Nojima Y; Maekawa N; Minato E; Kobayashi A; Ando R; Sasaki N; Miyakoshi D; Ichii O; Kato Y; Suzuki Y; Murata S; Ohashi K
PLoS One; 2020; 15(11):e0234218. PubMed ID: 33216754
[TBL] [Abstract][Full Text] [Related]
31. The association between detection of Mycobacterium avium subsp. paratuberculosis DNA in feces and histopathological classification.
Taniguchi Y; Sakakibara SI; Fujihara M; Yagi A; Fujiyoshi S
J Vet Med Sci; 2020 May; 82(5):541-545. PubMed ID: 32161236
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of PD-L1 Expression by Prostaglandin E
Goto S; Konnai S; Hirano Y; Kohara J; Okagawa T; Maekawa N; Sajiki Y; Watari K; Minato E; Kobayashi A; Gondaira S; Higuchi H; Koiwa M; Tajima M; Taguchi E; Uemura R; Yamada S; Kaneko MK; Kato Y; Yamamoto K; Toda M; Suzuki Y; Murata S; Ohashi K
Front Vet Sci; 2020; 7():12. PubMed ID: 32154274
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E
Sajiki Y; Konnai S; Okagawa T; Nishimori A; Maekawa N; Goto S; Watari K; Minato E; Kobayashi A; Kohara J; Yamada S; Kaneko MK; Kato Y; Takahashi H; Terasaki N; Takeda A; Yamamoto K; Toda M; Suzuki Y; Murata S; Ohashi K
J Immunol; 2019 Sep; 203(5):1313-1324. PubMed ID: 31366713
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E
Sajiki Y; Konnai S; Okagawa T; Nishimori A; Maekawa N; Goto S; Ikebuchi R; Nagata R; Kawaji S; Kagawa Y; Yamada S; Kato Y; Nakajima C; Suzuki Y; Murata S; Mori Y; Ohashi K
Infect Immun; 2018 May; 86(5):. PubMed ID: 29483289
[TBL] [Abstract][Full Text] [Related]
35. Bovine Immunoinhibitory Receptors Contribute to Suppression of Mycobacterium avium subsp. paratuberculosis-Specific T-Cell Responses.
Okagawa T; Konnai S; Nishimori A; Ikebuchi R; Mizorogi S; Nagata R; Kawaji S; Tanaka S; Kagawa Y; Murata S; Mori Y; Ohashi K
Infect Immun; 2016 Jan; 84(1):77-89. PubMed ID: 26483406
[TBL] [Abstract][Full Text] [Related]
36. The enhancement of Th1 immune response by anti-PD-L1 antibody in cattle infected with Mycobacterium avium subsp. paratuberculosis.
Sajiki Y; Konnai S; Nagata R; Kawaji S; Nakamura H; Fujisawa S; Okagawa T; Maekawa N; Kato Y; Suzuki Y; Murata S; Mori Y; Ohashi K
J Vet Med Sci; 2021 Feb; 83(2):162-166. PubMed ID: 33281144
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E
Sajiki Y; Konnai S; Watari K; Okagawa T; Tanaka A; Kawaji S; Nagata R; Maekawa N; Suzuki Y; Kato Y; Murata S; Mori Y; Ohashi K
Infect Immun; 2022 Oct; 90(10):e0021022. PubMed ID: 36102658
[TBL] [Abstract][Full Text] [Related]
38. Immune exhaustion during chronic infections in cattle.
Konnai S; Murata S; Ohashi K
J Vet Med Sci; 2017 Jan; 79(1):1-5. PubMed ID: 27725355
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
